Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析

◆英語タイトル:Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15488
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Omnicell Inc (OMCL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Omnicell Inc (Omnicell) is a provider of automation and business analytics software solutions. It provides medication control and patient safety solutions to enhance operational efficiency and patient care in acute healthcare facilities. The company offers automation solutions such as medication use products, nursing floor solutions, central pharmacy solutions, operating room solutions, and medical and surgical supply products. It also offers solutions to non-acute care products including blister cards; pharmacy sealers for medication packaging; automated fillers; pharmacy automation systems; pharmacy printing and labeling solutions, and medication management solutions. The company offers its products through own sales force, distributors and resellers in the US, Canada, the UK, Germany and other regions. Omnicell is headquartered in Mountain View, the US.

Omnicell Inc Key Recent Developments

Feb 07,2019 Omnicell reports results for fiscal year and fourth quarter 2018
Feb 04,2019 Omnicell’s automated medication dispensing system receives top KLAS award for the 13th consecutive year
Dec 05,2018 Northeast Georgia Health System Selects Omnicell Automated Medication Management Platform to Support Newly Redesigned Pharmacy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Omnicell Inc – Key Facts
Omnicell Inc – Key Employees
Omnicell Inc – Key Employee Biographies
Omnicell Inc – Major Products and Services
Omnicell Inc – History
Omnicell Inc – Company Statement
Omnicell Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Omnicell Inc – Business Description
Business Segment: Automation and Analytics
Overview
Performance
Business Segment: Medication Adherence
Overview
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Omnicell Inc – Corporate Strategy
Omnicell Inc – SWOT Analysis
SWOT Analysis – Overview
Omnicell Inc – Strengths
Omnicell Inc – Weaknesses
Omnicell Inc – Opportunities
Omnicell Inc – Threats
Omnicell Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Omnicell Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Omnicell Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Omnicell Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 07, 2019: Omnicell reports results for fiscal year and fourth quarter 2018
Feb 04, 2019: Omnicell’s automated medication dispensing system receives top KLAS award for the 13th consecutive year
Dec 05, 2018: Northeast Georgia Health System Selects Omnicell Automated Medication Management Platform to Support Newly Redesigned Pharmacy
Dec 03, 2018: Omnicell Launches vision for fully digitized, autonomous pharmacy at Annual ASHP Midyear Meeting
Oct 25, 2018: Omnicell achieves record revenue in the third quarter 2018
Oct 10, 2018: Augusta University Health selects Omnicell’s industry-leading medication management portfolio to support newly redesigned pharmacy
Oct 10, 2018: Augusta University Health Selects Omnicell s Industry-Leading Medication Management Portfolio to Support Newly Redesigned Pharmacy
Sep 18, 2018: Middlesex Hospital bolsters pharmacy safety and compliance by extending Wolters Kluwer’s Simplifi 797 with Omnicell’s IVX Workflow
Sep 14, 2018: Rob Seim to retire and join Omnicell board of directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Omnicell Inc, Key Facts
Omnicell Inc, Key Employees
Omnicell Inc, Key Employee Biographies
Omnicell Inc, Major Products and Services
Omnicell Inc, History
Omnicell Inc, Other Locations
Omnicell Inc, Subsidiaries
Omnicell Inc, Key Competitors
Omnicell Inc, Ratios based on current share price
Omnicell Inc, Annual Ratios
Omnicell Inc, Annual Ratios (Cont...1)
Omnicell Inc, Annual Ratios (Cont...2)
Omnicell Inc, Interim Ratios
Omnicell Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Omnicell Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Omnicell Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Omnicell Inc, Performance Chart (2014 - 2018)
Omnicell Inc, Ratio Charts
Omnicell Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Omnicell Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • LPP SA (LPP):企業の財務・戦略的SWOT分析
    LPP SA (LPP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Odonate Therapeutics Inc (ODT):製薬・医療:M&Aディール及び事業提携情報
    Summary Odonate Therapeutics Inc (Odonate), formerly Odonate Therapeutics LLC, is a pharmaceutical company that develops medicines for the treatment of cancer. The company provides product candidate, tesetaxel which is a novel orally administered taxane used for the treatment of advanced and metasta …
  • amcure GmbH-製薬・医療分野:企業M&A・提携分析
    Summary amcure GmbH (Amcure) is biopharmaceutical company which discovers and develops therapeutics for the treatment of cancer. It develops peptide-based compounds for the treatment of metastatic forms of cancer. The company’s lead candidate AMC303, is in Phase I clinical trial and used for the tre …
  • Domino’s Pizza, Inc.:企業の戦略・SWOT・財務情報
    Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report Summary Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Attijariwafa Bank SA (ATW):企業の財務・戦略的SWOT分析
    Attijariwafa Bank SA (ATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • BCE Inc.:戦略・SWOT・企業財務分析
    BCE Inc. - Strategy, SWOT and Corporate Finance Report Summary BCE Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • AEON Co Ltd (8267):企業の財務・戦略的SWOT分析
    AEON Co Ltd (8267) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mahaweli Reach Hotels Plc
    Mahaweli Reach Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Mahaweli Reach Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • C. R. Bard, Inc.:企業のM&A・事業提携・投資動向
    C. R. Bard, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's C. R. Bard, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • AvStar Aviation Services Inc:企業の戦略的SWOT分析
    AvStar Aviation Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Ig Group Holdings Plc:企業の戦略・SWOT・財務分析
    Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Croma-Pharma GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company that offers development and commercialization of drugs in the field of aesthetic dermatology. The company’s products include princess skincare, princess injectables, and princess lift products. Its princess skincare products compri …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • Hollard Insurance Group:企業の戦略・SWOT・財務情報
    Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank Of Cyprus Public Company Ltd:企業の戦略・SWOT・財務分析
    Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Synergy
    Synergy - Strategy, SWOT and Corporate Finance Report Summary Synergy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Asarco LLC:企業の戦略・SWOT・財務分析
    Asarco LLC - Strategy, SWOT and Corporate Finance Report Summary Asarco LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sensimed AG-医療機器分野:企業M&A・提携分析
    Summary Sensimed AG (Sensimed) is a medical device company that offers soft contact lens-based solutions. The company’s products comprise Sensimed Triggerfish, a non-invasive soft contact lens-based solution designed for the overall management of glaucoma. It offers automated recording of continuous …
  • Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆